文献速递复苏、休克与脓毒症心脑血管急症

COVID-19大流行对EMS目击院外心脏骤停后良好神经功能结局的影响:一项前瞻性全国观察性研究

Impact of the COVID-19 pandemic on favourable neurological outcome after EMS-witnessed out-of-hospital cardiac arrest: a prospective nationwide observational study.
PubMed 文献 · Resuscitation · 2025-08-07
一句话结论日本全国登记研究显示,COVID-19大流行期间EMS目击OHCA患者30天良好神经功能结局显著下降(RR 0.80),疫情蔓延地区下降更明显(RR 0.77)。

该研究利用日本前瞻性全国人口登记数据,采用中断时间序列分析,评估COVID-19大流行对EMS目击院外心脏骤停成人患者30天良好神经功能结局(CPC 1或2)、院前ROSC和30天生存的影响。共纳入58,315例EMS目击OHCA成人患者,比较大流行前(2016年1月至2020年3月)与大流行期间(2020年4月至2021年12月)的结局。结果显示,大流行期间良好神经功能结局显著下降(RR 0.80;95%CI 0.71-0.91;p<0.001),院前ROSC和30天生存也显著下降(p<0.05)。亚组分析显示,疫情蔓延地区良好神经功能结局下降(p<0.001),而未受影响地区无显著变化(p=0.243);对照ITSA显示疫情蔓延地区较未受影响地区下降更显著(RR 0.77;95%CI 0.60-0.98;p=0.035)。

要点

  • 大流行期间EMS目击OHCA成人患者30天良好神经功能结局(CPC 1或2)显著下降:RR 0.80(95%CI 0.71-0.91;p<0.001)。
  • 大流行期间院前ROSC和30天生存也显著下降(p<0.05)。
  • 疫情蔓延地区良好神经功能结局显著下降(p<0.001),未受影响地区无显著变化(p=0.243)。
  • 对照ITSA显示疫情蔓延地区较未受影响地区良好神经功能结局下降更显著:RR 0.77(95%CI 0.60-0.98;p=0.035)。
  • 研究共纳入58,315例EMS目击OHCA成人患者,比较大流行前(2016年1月至2020年3月)与大流行期间(2020年4月至2021年12月)。

适用人群与场景

  • 日本成人EMS目击院外心脏骤停患者,纳入前瞻性全国人口登记,大流行前(2016年1月至2020年3月)与大流行期间(2020年4月至2021年12月)共58,315例。

研究设计与关键结果

  • 研究类型:前瞻性全国人口登记的中断时间序列分析(ITSA),共纳入58,315例EMS目击OHCA成人患者。
  • 主要终点:大流行期间30天良好神经功能结局(CPC 1或2)显著下降,RR 0.80(95%CI 0.71-0.91;p<0.001)。
  • 关键次要终点:院前ROSC和30天生存也显著下降(p<0.05)。
  • 亚组分析:疫情蔓延地区良好神经功能结局下降(p<0.001),未受影响地区无显著变化(p=0.243)。
  • 对照ITSA:疫情蔓延地区较未受影响地区良好神经功能结局下降更显著,RR 0.77(95%CI 0.60-0.98;p=0.035)。

证据类型、等级与局限

  • 证据类型:前瞻性、全国、基于人群的登记研究,采用中断时间序列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To evaluate the impact of the COVID-19 pandemic on favourable neurological outcome after out-of-cardiac arrest (OHCA) witnessed by emergency medical services (EMS) personnels in Japan.

METHODS: We conducted an interrupted time series analysis (ITSA) using a prospective, nationwide, population-based registry in Japan to assess 30-day favourable neurological outcome (Cerebral Performance Category 1 or 2), prehospital return of spontaneous circulation (ROSC), and 30-day survival among adult patients with EMS-witnessed OHCA during the pre-pandemic (January 2016-March 2020) and pandemic (April 2020-December 2021) periods. Subgroup analyses were performed by stratifying regions based on state of emergency declaration status. A controlled ITSA was conducted to compare outcome trends between areas with and without significant COVID-19 spread.

RESULTS: In total, 58,315 adult patients with EMS-witnessed OHCA were identified. Favourable neurological outcome significantly declined during the pandemic (relative risk [RR], 0.80; 95 % CI, 0.71-0.91; p < 0.001). Prehospital ROSC and 30-day survival also decreased significantly (p < 0.05). In subgroup analyses, favourable neurological outcome declined in areas affected by COVID-19 spread (p < 0.001), while no significant change was observed in unaffected areas (p = 0.243). The controlled ITSA revealed a significantly greater decline in favourable neurological outcome in areas with COVID-19 spread compared with unaffected areas (RR, 0.77; 95 % CI, 0.60-0.98; p = 0.035).

CONCLUSION: Favourable neurological outcomes among patients with EMS-witnessed OHCA in Japan were lower during the COVID-19 pandemic, particularly in regions affected by COVID-19 spread.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Tsunemitsu T, Nishioka N, Imamura T, et al. Impact of the COVID-19 pandemic on favourable neurological outcome after EMS-witnessed out-of-hospital cardiac arrest: a prospective nationwide observational study. Resuscitation. 2025. PMID: 40783093. doi:10.1016/j.resuscitation.2025.110758

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。